2+ day, 20+ hour ago   (387+ words) Fund I will invest across therapeutics, medical devices, diagnostics, and digital health, targeting companies from Series A through growth stages in the US, Europe, and Israel. Luma Group has closed its debut life sciences fund at $410 million, marking another sizable…...

3+ day, 2+ hour ago   (568+ words) Life sciences dealmaking hits record highs as biopharma bets big on early-stage assets amid geopolitical uncertainty. The first half of 2026 has delivered the strongest run of life sciences dealmaking on record, according to a report published by EY - a long-term…...

3+ day, 23+ hour ago   (1031+ words) Three leaders shared how straight talk, low egos, and cost efficiency are turning Scandinavian startups into pharma's trusted collaborators. The Nordic biotech ecosystem could be said to be punching above its weight, and three CEOs at the heart of this…...

4+ day, 23+ hour ago   (402+ words) Moonwalk Biosciences has closed a $70 million Series B to push adipose-targeted RNAi obesity candidate into the clinic. Moonwalk is developing small interfering RNA (siRNA) therapeutics designed to act directly on adipose tissue, targeting non-incretin biology inside the fat cell itself....

1+ week, 12+ hour ago   (494+ words) In a deal that could be worth close to $1.3 billion, HUTCHMED has signed a licensing agreement with GSK for one of its oncology assets. HUTCHMED Limited has granted a subsidiary of GSK, GlaxoSmithKline Intellectual Property (No.4) Limited, worldwide rights to…...

1+ week, 3+ day ago   (311+ words) Roche has struck an exclusive global licensing agreement for SIM0660, a preclinical trispecific antibody aimed at B-cell-mediated diseases. "This agreement with Simcere Zaiming reflects our commitment to partnering with innovative companies to advance and deliver new therapeutic options for patients in…...

1+ week, 5+ day ago   (414+ words) The life sciences sector is experiencing a fundamental shift in how innovation ecosystems operate. While geographic clusters of hospitals, universities, and research institutions have long been considered the gold standard for biotech development, industry leaders at Asia Bio Partnering Forum…...

1+ week, 5+ day ago   (206+ words) Initial rejection rates for negotiated medications remain at 24%, with immunology and oncology hit hardest. Nearly a quarter of patients attempting to fill prescriptions for Medicare-negotiated drugs faced initial rejections in the first quarter of 2026, matching rates from the previous year…...

2+ week, 3+ day ago   (305+ words) Haisco Pharmaceutical Group has signed a licensing agreement with Sentivera, a newly formed US venture backed by Population Health Partners and ARCH Venture Partners. The deal is valued at over $1.5 billion and will grant Sentivera global rights to develop, manufacture,…...

2+ week, 4+ day ago   (509+ words) Pop star Lady Gaga unveils her board role at Outer Bio, a Massachusetts biotech using human skin tissue to develop new compounds. “Meet Outer Bio and Yuna. We are building the future of skin health,” she wrote on Instagram. Outer…...